To include your compound in the COVID-19 Resource Center, submit it here.

DNA beats Street EPS

Genentech (DNA) announced after the market close second quarter EPS of $0.23, a penny better than the Street's estimate, driven by strong

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE